Tamara Fraizer

Life Sciences

• Counseling a biotech company on US and European patent priority disputes with a competitor involving certain uses of CRISPR technology.
• Defended a medical device company in litigation involving patents related to optimization methods used in radiation therapy treatment planning. Filed four petitions for inter partes review (IPR) of the asserted patents and argued appeal of IPR decisions resulting in invalidation of asserted patent claims. Case settled favorably thereafter.
• Defended a medical device company against claims of infringement of patent for user interface of surgical equipment, uncovering and developing facts through third party discovery to invalidate patent while also challenging validity in an IPR petition. Case settled favorably before completion of discovery.
• Developing a patent portfolio for a company providing manipulations of the gut microbiome in pets to improve digestive health.
• Developing a patent portfolio relating to systems and methods for microtissue assays.
• Represented a medical device company in assertion of patent on systems and methods for radiotherapy treatment against a global competitor, coordinated the handling of proceedings between the same parties in the US, UK, Germany and the US PTO, and worked with the client to settle all matters..
• Represented a healthcare product company in assertion of patents on cold compression therapy and assisted with prosecution of patents. Settled case with minimal litigation.
• Represented a pharmaceutical company in assertion of newly issued patents on an ophthalmic NSAID formulation against three companies having generic versions already on the market. All cases settled favorably during discovery or after Markman order.
• Represented a biotechnology company, taking over longstanding litigation between the parties after appeal to the Federal Circuit. Conducted trial focused on inventorship of RNase H minus reverse transcriptase and potential damages. Case settled during trial.
• Represented a biotechnology company in a case involving inventorship and ownership dispute of polymerase blends for use in PCR. Obtained favorable cross-license and settlement.
• Defended a pharmaceutical company in one of many multiparty litigations brought by another pharmaceutical company regarding methods and compositions for treatment of the skin. Successfully limited potential liability. Case settled.
• Defended a biotechnology company in a patent infringement suit regarding fluorescence polarization assay for kinase reaction. Defeated preliminary injunction motion. Case settled after Markman hearing.
• Represented a biotechnology company in assertion of patents for a genetically modified tissue plasminogen activator, implicating products used for treatment of acute myocardial infarction. Case settled for favorable cross-license.

Software/Devices

• Working to develop and enforce foundational patents directed to certain trading of futures and options.
• Advising various companies on matters involving internet and software patents held by monetizing entities.
• Defended an advertising company against claims of copyright infringement for use of internet games. Obtained early settlement.
• Defended genetics company against allegations of infringement of software patents, developing prior art product facts to leverage favorable settlement.
• Defended a global technology corporation against claims of infringement of early 1990’s patent on certain aspects of relational databases. Case settled favorably with limited discovery.
• Defended and asserted patents of an energy efficient lighting manufacturer in a multi-patent litigation between competitors concerning their occupancy sensor light switch products. Resolved favorably prior to trial.
• Represented the licensee of a garage door opener manufacturer in a patent infringement action concerning security algorithm software and transmitter hardware for use in garage door technology. Resolved to the satisfaction of the client prior to trial.
• Defended a software company in a patent infringement suit brought by a competitor regarding software for wireless communications. Parties merged after trial.
• Represented a design automation company in assertion of patent infringement claims implicating an electronic design automation company’s popular chip design software. Case settled after Markman hearing and expert reports.

Other Technologies

• Successfully defended consumer products company in follow-on case alleging breach of contract and infringement of patents on percussive massage devices, with strategic assertion of venue and invalidity challenges and negotiation. Case settled early and favorably.
• Defended hoverboard distributor in litigation on foundational hoverboard patents, defeating motion for preliminary injunction and handling extended negotiations resulting in settlement of the litigation and licensing of the patents.
• Settled cofounder dispute involving rights to clothing patent and polymer technology on the eve of trial.
• Successfully defended a client in a multi-patent investigation concerning the design, manufacture and use of probe card assemblies. Invalidated claims of two patents and demonstrated no infringement of any of the asserted patents, with determination affirmed by the ITC.
• Successfully asserted patents relating to circuits used in power supplies. Jury found that defendant had willfully infringed all four patents asserted in the case, and awarded damages of US$34 million. A second jury found all asserted claims not invalid.
• Represented an electronic components supplier in assertion of patents on circuits used in power supplies. Prevailed at trial in the ITC, where the patents were found to be valid and infringed, and obtained order excluding downstream products from importation into the US. Decision upheld on appeal to the Federal Circuit.
• Represented a technology company in multi-forum dispute involving 34 patents on various technologies used in cell phones. Case settled favorably.